This episode covers the jury verdict in our case (nearly $20M in damages), then runs a clinical debrief — examining the readmission decision, the diagnostic gap around bronchoscopy and fungal workup timing, the ARDS threshold window, drug selection (itraconazole vs. liposomal amphotericin B), and system-level fixes. Wraps with legal lessons on documentation and how the appellate ruling changed summary judgment standards.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thecharteddefense.substack.com/subscribe